Le Lézard
Classified in: Health
Subjects: TDS, FVT

BD to Present at the Barclays Global Healthcare Conference



FRANKLIN LAKES, N.J., March 8, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Barclays Global Healthcare Conference on Wednesday, March 14, 2018, at 1:35 p.m. ET.

A live webcast of BD's presentations can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Wednesday, March 21, 2018. 

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.

Contact:
Kristen Cardillo, Communications ? 201-847-5657
Monique N. Dolecki, Investor Relations ? 201-847-5378

SOURCE BD (Becton, Dickinson and Company)


These press releases may also interest you

at 20:07
2019-2023 Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers Read the full report:...

at 20:07
Executive Summary Specialty (Except Psychiatric and Substance Abuse) Services supply diagnostic medical treatment to inpatients with specific types of disease or medical condition excluding psychiatric and substance abuse services. This industry...

at 20:07
2019-2023 Diagnostic Testing in Physician Offices and Group Practices: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers Read the full report:...

at 20:07
US In Vitro Diagnostics Industry 2019-2023: Supplier Shares by Test, Segment Volume and Sales Forecasts, Instrumentation Review, Opportunities for Suppliers Read the full report: https://www.reportlinker.com/p05288328 This new report provides an...

at 20:07
Executive Summary Psychiatric and substance abuse services provide diagnostic, medical treatment and monitoring services for inpatients suffering from mental disorders or substance abuse disorders. Specialist physicians and other medical staff...

at 20:07
2019-2023 Orthopedics Market Segment Forecasts, Supplier Strategies, Marketing TacticsThis report provides a worldwide strategic overview of the orthopedics market, including: Read the full report: https://www.reportlinker.com/p03312685 In addition,...




News published on 8 march 2018 at 16:30 and distributed by: